Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Development of Inflammatory Arthritis following Withdraw of Efalizumab (Raptiva,Monoclonal Anti-Cd11A) for Psoriasis

Journal of Investigative Medicine

Impact Factor: 1.9 / 5-Year Impact Factor: 2.1

Journal Homepage Submission guidelines

Restricted access

Research article

First published online January, 2005

Development of Inflammatory Arthritis following Withdraw of Efalizumab (Raptiva,Monoclonal Anti-Cd11A) for Psoriasis

Volume 53, Issue 1_part_2

https://doi.org/10.1177/1081558905053001290

Abstract

Get full access to this article

View all access options for this article.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Restricted access

Exploratory Grant Program in Diabetes,Endocrinology,and Metabolism: Pa-04-137

Restricted access

Comings and Goings

Restricted access

Benefit of Multiple Daily Injections of Insulin Prior To Insulin Pump Therapy in Type 1 Diabetes

Restricted access

Pegaspargase Induced Severe Pancreatitis. Friend or Foe?